Paper41599016
Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins.
Gonepudi NK and 4 others. Pathogens, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Structure-Guided Design of Peptide Inhibitors Targeting Class I Viral Fusion Proteins. Papers, record 41599016. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41599016
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Viral Fusion Proteins | Major topic |
| Peptides | Major topic |
| Antiviral Agents | Major topic |
| Viral Fusion Protein Inhibitors | Major topic |
| Drug Design | Major topic |
| Humans | |
| Virus Internalization |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R01 AI181600 | NIAID NIH HHS | United States | R01AI181600 | PubMed and NIH | NIH RePORTER |
| R35 GM151169 | NIGMS NIH HHS | United States | R35GM151169 | PubMed and NIH | NIH RePORTER |
| R35GM151169 | NIGMS NIH HHS | United States | R35GM151169 | PubMed and NIH | NIH RePORTER |
| R01AI181600 | National Institute of Allergy and Infectious Diseases | R01AI181600 | PubMed and NIH | NIH RePORTER |
References191
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33068234 | Influenza Hemagglutinin Head Domain Mimicry by Rational Design. | Protein J | 2020 | https://conductscience.org/library/papers/33068234 | PubMed |
| 2 | 32805734 | Structures and distributions of SARS-CoV-2 spike proteins on intact virions. | Nature | 2020 | https://conductscience.org/library/papers/32805734 | PubMed |
| 3 | 24067982 | Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus. | J Virol | 2013 | https://conductscience.org/library/papers/24067982 | PubMed |
| 4 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 5 | 21613394 | Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. | J Virol | 2011 | https://conductscience.org/library/papers/21613394 | PubMed |
| 6 | 23565220 | Conjugation of cholesterol to HIV-1 fusion inhibitor C34 increases peptide-membrane interactions potentiating its action. | PLoS One | 2013 | https://conductscience.org/library/papers/23565220 | PubMed |
| 7 | 32376627 | Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity. | J Virol | 2020 | https://conductscience.org/library/papers/32376627 | PubMed |
| 8 | 12600315 | Membrane fusion. | Cell | 2003 | https://conductscience.org/library/papers/12600315 | PubMed |
| 9 | 23804636 | A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo. | J Virol | 2013 | https://conductscience.org/library/papers/23804636 | PubMed |
| 10 | 28423338 | An Amphibian Host Defense Peptide Is Virucidal for Human H1 Hemagglutinin-Bearing Influenza Viruses. | Immunity | 2017 | https://conductscience.org/library/papers/28423338 | PubMed |
| 11 | 39070180 | Development of potent pan-coronavirus fusion inhibitors with a new design strategy. | MedComm (2020) | 2024 | https://conductscience.org/library/papers/39070180 | PubMed |
| 12 | 15150417 | Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. | Proc Natl Acad Sci U S A | 2004 | https://conductscience.org/library/papers/15150417 | PubMed |
| 13 | 24743141 | Repurposing staples for viruses: applying peptide design to RSV prophylaxis. | J Clin Invest | 2014 | https://conductscience.org/library/papers/24743141 | PubMed |
| 14 | 24473083 | Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor. | Nat Commun | 2014 | https://conductscience.org/library/papers/24473083 | PubMed |
| 15 | 12615056 | Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion. | Biochem Biophys Res Commun | 2003 | https://conductscience.org/library/papers/12615056 | PubMed |
| 16 | 8312047 | A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion. | AIDS Res Hum Retroviruses | 1993 | https://conductscience.org/library/papers/8312047 | PubMed |
| 17 | 33914735 | Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. | PLoS Biol | 2021 | https://conductscience.org/library/papers/33914735 | PubMed |
| 18 | 39640534 | HIV-1-envelope trimer transitions from prefusion-closed to CD4-bound-open conformations through an occluded-intermediate state. | Comput Struct Biotechnol J | 2024 | https://conductscience.org/library/papers/39640534 | PubMed |
| 19 | 37039514 | Rapid Evaluation of Staple Placement in Stabilized α Helices Using Bacterial Surface Display. | ACS Chem Biol | 2023 | https://conductscience.org/library/papers/37039514 | PubMed |
| 20 | 31262533 | Molecular Mechanism of HIV-1 Entry. | Trends Microbiol | 2019 | https://conductscience.org/library/papers/31262533 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42466597 | Identification of Two Competition-Defined Neutralizing Antibody Groups Targeting the HHV-6B gH/gL/gQ1/gQ2 Complex Independent of CD134 Binding. | Microbiol Immunol | 2026 | https://conductscience.org/library/papers/42466597 | PubMed |
| 42357691 | Membrane-Anchored and Sequence-Oriented Antiviral Activity of Fusion-Inhibitory Lipopeptides Derived from the SARS-CoV-2 Spike Glycoprotein S2 Subunit. | Viruses | 2026 | https://conductscience.org/library/papers/42357691 | PubMed |
| 42082899 | Targeting Middle East Respiratory Syndrome Coronavirus Spike Fusion Machinery With Antiviral Peptides: In Silico Exploration of the Heptad Repeat 2 Domain. | Microbiologyopen | 2026 | https://conductscience.org/library/papers/42082899 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41599016
GET https://conductscience.org/api/papers/v1/41599016/references?page=2